Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Wall Street Bulls Look Optimistic About Amphastar (AMPH): Should You Buy?
10:30am, Thursday, 22'nd Feb 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
04:01pm, Tuesday, 20'th Feb 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / February 20, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2023 ended December 31,
It May Be Time To Revisit Amphastar Once It Settles After A Plunge
08:00am, Friday, 16'th Feb 2024
Drug stock Amphastar Pharmaceuticals took a nasty drop in January after nearing highs. It may time to take another look as earnings approach.
Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why
06:46pm, Friday, 09'th Feb 2024
In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $55.61, denoting a +1.85% change from the preceding trading day.
3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential
12:41pm, Monday, 05'th Feb 2024
The biotech sector is one of my favorite sectors since it is not only constantly growing and with companies that are always doing wonderful research, products, and solutions, but it is also a sector t
Amphastar Pharmaceuticals (AMPH) Falls More Steeply Than Broader Market: What Investors Need to Know
06:56pm, Tuesday, 30'th Jan 2024
In the most recent trading session, Amphastar Pharmaceuticals (AMPH) closed at $54.94, indicating a -0.81% shift from the previous trading day.
5 Top Growth Stocks to Buy as Recession Fears Subside
09:25am, Friday, 26'th Jan 2024
Invest in growth stocks such as Amphastar Pharmaceuticals (AMPH), Abercrombie & Fitch (ANF), Cameco (CCJ), CyberArk Software (CYBR) and LendingTree (TREE) as the U.S. economy defies recession fears.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
11:36am, Thursday, 25'th Jan 2024
With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
Snap these 4 Top-Ranked Liquid Stocks to Drive Solid Returns
08:16am, Monday, 15'th Jan 2024
Here are four top-performing liquid stocks, American Public Education (APEI), Amphastar Pharmaceuticals (AMPH), GigaCloud (GCT) and Oceaneering International (OII), which investors can add to their po
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
07:34pm, Thursday, 11'th Jan 2024
Amphastar Pharmaceuticals (AMPH) concluded the recent trading session at $54.03, signifying a -1.44% move from its prior day's close.
Amphastar Pharmaceuticals (AMPH) Stock Drops Despite Market Gains: Important Facts to Note
07:34pm, Friday, 05'th Jan 2024
Amphastar Pharmaceuticals (AMPH) concluded the recent trading session at $62.74, signifying a -1.12% move from its prior day's close.
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
06:00am, Tuesday, 02'nd Jan 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / January 2, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Dr. Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at t
Amphastar Pharmaceuticals (AMPH) Is Up 1.53% in One Week: What You Should Know
01:32pm, Monday, 01'st Jan 2024
Does Amphastar Pharmaceuticals (AMPH) have what it takes to be a top stock pick for momentum investors? Let's find out.
4 Promising Liquid Stocks to Boost Your Portfolio in 2024
09:01am, Friday, 29'th Dec 2023
Building a portfolio comprising stocks with favorable liquidity is the way to go for investors seeking healthy returns.
What Awaits These 4 Drug Stocks That More Than Doubled in 2023?
10:31am, Tuesday, 26'th Dec 2023
Here are four drug, biotech stocks, AMPH, DERM, CNTA & AQST, which have more than doubled in 2023 with room for further growth in 2024.
